Skip to main content

Table 1 Definitions of dysglycaemia according to WHO and ADA

From: Undetected dysglycaemia common in primary care patients treated for hypertension and/or dyslipidaemia: on the need for a screening strategy in clinical practice. A report from EUROASPIRE IV a registry from the EuroObservational Research Programme of the European Society of Cardiology

Test/diagnose

Cut off level

HbA1c

% DCCT

mmol/mol IFCC

High risk HbA1c

5.7–6.4

39–47

Diabetes

≥ 6.5

≥ 48

Plasma glucose

mmol/l

mg/dl

Impaired fasting glucose

 Fasting

6.1–6.9

110–125

 2 h postload

< 11.0

< 200

Impaired glucose tolerance

 Fasting

< 7.0

< 126

 2 h postload

≥ 7.8–11.0

≥ 140–199

Diabetes

 Fasting

> 7.0

> 126

 2 h postload

≥ 11.1

≥ 200